Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe glossary is now displayed, QC-related labels have been updated (Last Update Submitted that Met QC Criteria) with the footer text showing No FEAR Act Data, and the site revision is now Revision: v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous v3.3.3. This is a minor site maintenance update and does not affect study details or other visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section listing California, Illinois, and Pennsylvania. Removed the separate California Locations, Illinois Locations, and Pennsylvania Locations entries.SummaryDifference0.4%

- Check92 days agoChange DetectedThe changes are minor editorial updates: addition of a PubMed-related publication note and a revision history update from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.